Stocksigma LogoStocksigma Logo

Piramal Pharma to Conclude Distribution Agreement with Bayer Pharmaceuticals

Piramal Pharma announced that its commercial arrangement providing sales and distribution support services to Bayer Pharmaceuticals will conclude upon

Piramal Pharma to Conclude Distribution Agreement with Bayer Pharmaceuticals

Piramal Pharma Ltd 路 Others (Uncategorized) 路 02 Oct 2026, 1:40 am

Piramal Pharma to Conclude Distribution Agreement with Bayer Pharmaceuticals Piramal Pharma announced that its commercial arrangement providing sales and distribution support services to Bayer Pharmaceuticals will conclude upon natural expiry on 31st Dec'26, with no renewal beyond the current term. The company earned commission-based income under this pact, which accounts for under 5% of its consolidated revenue. Given its commission-based structure, the non-renewal is not expected to have a material impact on Piramal Pharma's profitability or overall financial position, and the company is working with Bayer to ensure an orderly operational transition.

Original exchange filing (PDF)

More announcements from Piramal Pharma Ltd

All Piramal Pharma Ltd announcements